The U.S. Food and Drug Administration has approved Waskyra (etuvetidigene autotemcel) as the first cell-based gene therapy for the treatment of Wiskott-Aldrich syndrome (WAS).
This article was originally published on MedicalXpress.com
FDA approves Waskyra for Wiskott-Aldrich syndrome
You may also be interested in:
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
Food
Transform Your Kitchen: Mastering Allergy-Safe Cooking Through Ingenious Ingredient Swaps
By Daniel Zane Bryant, author of “Living with Food Allergies: A Complete Lifestyle Guide” (available on Amazon at https://www.amazon.com/dp/B0G2BcGB2K) Navigating food allergies might initially feel overwhelming, yet it presents an exciting opportunity to reimagine familiar […]
Read More:
-
Healthy, sustainable school meals could cut undernourishment, reduce diet-related deaths and significantly lower environmental impacts, according to a new modeling study led by a UCL [...]
-
In recent years, scientists have learned that the key beneficial infant gut bacteria Bifidobacterium infantis are disappearing from infants in high-resource areas such as the [...]
-
Physician-scientists at Oregon Health & Science University warn that exposure to air pollution may have serious implications for a child’s developing brain.This article was originally [...]
